Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Cancer cell · 2024
    DBDarko BarisicCCChristopher ChinCMCem MeydanACAmy Chadburn+4 more →AMAri M. Melnick
    PMID: 38458187PMCID: PMC11407687DOIFirst author53 citations

Publications

19 publications

Funding

13 grantsView NIH portfolio on RePORTER ↗

Active

10 grants
  • Co-I
    A phase Ib trial of FHD-286 plus mosunetuzumab in previously treated follicular lymphoma
    Follicular Lymphoma Foundation · 2026–2031
    FLF 261485-01
  • KP
    Collaborative Subcontract with University of Texas M.D. Anderson Cancer Center and Dr. Melnick
    MD Anderson Cancer Center · 2024–2029
    No publications yet
    MDACC 253204-01
  • PI
    Role of Chromatin Remodeling Complexes in Clonal Evolution of Blood Cancers
    American Cancer Society · 2026–2027
    CAT-26-1609195-01-CAT-W25
  • MPI
    Define genetically/epigenetically modified targets in the immune niche of DLBCLs- Project 2
    Leukemia & Lymphoma Society · 2022–2027 · via University Health Network
    UHN 224060-01
  • PI
    Role of chromatin remodeling complex BAF in immunity and lymphoma
    National Cancer Institute · 2024–2027
    R00CA246080-05
  • PI
    Chromatin Remodeling Complexes as Drivers of Resistance in Acute Myeloid Leukemia
    Leukemia Research Foundation · 2025–2027
    LRF 1482383
  • KP
    The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
    National Cancer Institute · 2025–2027 · via New York University School of Medicine (Grossman)
    No publications yet
    P01CA229068-06A1
  • Sub-PI
    How the immune system becomes malignant
    Starr Cancer Consortium · 2024–2026 · via Broad Institute Inc
    I17-0131
  • Sub-PI
    The role of chromatin loop extrusion in lymphomagenesis and therapeutic targeting - Project 1
    Leukemia & Lymphoma Society · 2024–2026 · via University of Florida
    USF 240838-01
  • KP
    Modulation of the Epigenome to Enhance CART Therapy against Non-Hodgkin Lymphoma
    Lymph & Co · 2024–2025 · via University of Pennsylvania
    500716
Completed grants (3)
  • PI
    Role of Chromatin Remodeling Complex BAF in Immunity and Lymphoma
    National Cancer Institute · 2020–2024· 2 renewals
    K99CA246080-02S1
  • PI
    Role of chromatin remodeling complex BAF in lymphomagenesis
    National Cancer Center, Inc. · 2019–2020
    NCC 201044-01
  • PI
    National Cancer Center Postdoctoral Fellowship
    National Cancer Center, Inc. · 2018–2019Fellowship
    NCC 182269-01

News mentions

2 mentionsView all WCM news ↗
  • A Unifying Mechanism for Cancer-Driving Mutations
    October 28, 2026

    A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.

  • Discovery Suggests New Strategy Against Follicular Lymphoma
    March 28, 2024

    A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.

Media highlights

1 clip

Mentoring

4 menteesAll publications with mentees →